Clinical efficacy of the use of the preparation “CELEXIB” in the treatment of crucilateral ligament injury of the knee joint in dogs
Bulletin "Veterinary biotechnology" · 29.05.2026 · 48 (14) · 108-120
DOI: 10.31073/vet_biotech48-07 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin "Veterinary biotechnology", online erschienen am 29.05.2026. Verfasst von M. Kondratyuk und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Injuries of the cruciate ligament of the knee joint in dogs are a common pathology of the musculoskeletal system, accompanied by pain, inflammation and impaired limb function. The effectiveness of the treatment of such injuries largely depends on the use of modern non-steroidal anti-inflammatory drugs, in particular selective cyclooxygenase-2 inhibitors. In this regard, it is relevant to study the clinical efficacy of the drug "Celexib" in the treatment of cruciate ligament injuries in dogs.
Zitieren
APA
Kondratyuk, M., Hunchak, V., & Sachuk, R. (2026). Clinical efficacy of the use of the preparation “CELEXIB” in the treatment of crucilateral ligament injury of the knee joint in dogs. Bulletin "Veterinary biotechnology", 48(14), 108-120. https://doi.org/10.31073/vet_biotech48-07
Vancouver
Kondratyuk M, Hunchak V, Sachuk R. Clinical efficacy of the use of the preparation “CELEXIB” in the treatment of crucilateral ligament injury of the knee joint in dogs. Bulletin "Veterinary biotechnology". 2026;48(14):108-120. doi:10.31073/vet_biotech48-07
BibTeX
@article{Kondratyuk2026,
author = {Kondratyuk, M. and Hunchak, V. and Sachuk, R.},
title = {Clinical efficacy of the use of the preparation “CELEXIB” in the treatment of crucilateral ligament injury of the knee joint in dogs},
journal = {Bulletin "Veterinary biotechnology"},
year = {2026},
volume = {48},
number = {14},
pages = {108--120},
doi = {10.31073/vet_biotech48-07}
}
EUVIMED